BPI France, Ixo Private Equity and the Irdinov fund have backed the creation of new French biotech firm GamaMabs Pharma with a €3.1m investment, working in partnership with French pharma group LFB.
Deal includes three manufacturing facilities located in Spain, which employ around 140 staff
GP acquired the care home group from Swiss Prime Site and will be the company's sole shareholder
Iris, Idinvest and historical backers invest in the manager of the eponymous social media app
GP uses its Mérieux Participations 3 fund, which held a first close on €200m in 2018